Saturday 17 October 2026
Export AVAH’s income statement to Excel — free account
Aveanna Healthcare Holdings Inc.
AVAH Healthcare Medical Care Facilities
Aveanna Healthcare Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 20.2% from fiscal 2024. In the quarter to June 2026, revenue grew 13.7%, EPS grew 46.2%, free cash flow grew 57.9% and total debt rose 1.07%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
12.34
0.30
−2.37%
Follow AVAH
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 5 | 6 | 3 | — | — | — | — | — |
P/E ratio |
7.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
0.68 | 0.44 | 0.28 | 0.07 | 0.75 | 1.10 | 1.10 | 1.10 | — |
Altman Z-Score |
1.45 | 0.62 | 0.15 | (1.19) | 0.74 | — | — | — | — |
Altman Z″-Score (non-manufacturers) |
(0.46) | (2.25) | (2.98) | (5.10) | (0.70) | (0.36) | — | 0.36 | — |
P/FCF ratio |
14.04 | 33.50 | 31.67 | 0.00 | 0.00 | 60.74 | 60.74 | 60.74 | — |
P/Operating CF |
33.44 | 65.76 | (174.47) | (3.27) | (37.65) | (51.82) | (51.82) | (51.82) | — |
Beneish M-Score |
(2.10) | (2.46) | (2.89) | (4.32) | (2.46) | — | — | — | — |
P/B ratio |
8.55 | 0.00 | 0.00 | 0.00 | 1.99 | 6.28 | 6.28 | 6.28 | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
EV/Sales |
1.21 | 1.11 | 1.01 | 0.86 | 1.54 | 1.81 | 1.81 | 1.81 | — |
EV/EBITDA |
10.10 | 12.74 | 12.94 | 19.37 | 20.59 | 23.06 | 23.06 | 23.06 | — |
EV/Operating CF |
23.32 | 68.84 | 84.72 | (31.87) | (227.95) | 70.90 | 70.90 | 70.90 | — |
EV/FCF |
24.78 | 85.37 | 116.02 | (25.54) | (94.77) | 100.12 | 100.12 | 100.12 | — |
Quick Ratio |
1.20 | 0.90 | 0.82 | 0.75 | 0.74 | 1.22 | 0.99 | 1.01 | — |
Current Ratio |
1.32 | 0.98 | 0.89 | 0.83 | 0.81 | 1.31 | 1.10 | 1.09 | — |
Net Debt/EBITDA |
4.38 | 7.74 | 9.41 | 17.71 | 10.54 | 9.42 | 14.86 | 10.61 | — |
Debt/Assets |
72.79% | 87.15% | 89.31% | 83.56% | 58.05% | 63.63% | 0.00% | 61.38% | 0.00% |
Debt/Equity |
7.53 | (11.73) | (11.12) | (226.67) | 2.13 | 4.43 | 0.00 | 2.76 | — |
Asset Turnover |
1.32 | 1.24 | 1.14 | 0.88 | 0.80 | 0.88 | 1.78 | 1.62 | — |
Operating CF/Net income |
0.56 | (2.99) | (0.17) | 0.07 | 0.10 | (2.04) | 0.11 | (0.46) | — |
Capex/Depreciation |
(0.22) | (0.17) | (0.04) | (0.02) | (0.10) | (0.13) | (0.49) | 0.00 | — |
Interest Coverage |
1.83 | 0.89 | 0.05 | (5.96) | (0.52) | (0.04) | 0.42 | 2.00 | — |
| 634.70% | 8.64% | 198.00% | (210.33%) | (25.99%) | (21.33%) | (24.88%) | (15.28%) | — | |
| 12.24% | (0.67%) | (8.09%) | (32.72%) | (5.60%) | (3.36%) | (9.87%) | (6.06%) | — | |
ROIC |
10.93% | 7.04% | 0.40% | (28.58%) | (1.15%) | (0.17%) | 2.25% | 0.00% | — |
Return on Tangible Assets |
147.63% | (138.76%) | 696.15% | 1,947.50% | 341.81% | (50.54%) | (78.88%) | (106.82%) | — |
Average Days of Receivables |
47.42 | 50.06 | 47.34 | 46.07 | 48.99 | 44.16 | 43.25 | 55.59 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
15.39% | 17.43% | 19.05% | 19.98% | 17.72% | 16.12% | 16.46% | 24.00% | — |
Intangible Assets out of Total Assets |
0.60 | 0.69 | 0.71 | 0.73 | 0.83 | 0.75 | 0.00 | 0.82 | 0.00 |
Share Based Compensation of Revenue |
1.03% | 0.86% | 0.69% | 0.89% | 0.86% | 0.22% | 0.14% | 0.00% | — |
Graham Net Nets |
(0.76) | (1.58) | (2.72) | (10.99) | (1.12) | (0.72) | (0.72) | (0.72) | — |
Graham Number |
4.82 | 0.93 | 3.28 | 1.65 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
13.22% | (1.31%) | (25.36%) | (502.82%) | (8.41%) | (5.32%) | (5.32%) | (5.32%) | — |
Free Cash Flow Yield |
7.12% | 2.99% | 3.16% | (45.86%) | (2.16%) | 1.65% | 1.65% | 1.65% | — |
Revenue per Share |
11.96 | 10.50 | 9.98 | 9.63 | 9.84 | 10.61 | 10.11 | 6.74 | — |
Operating CF per Share |
0.62 | 0.17 | 0.12 | (0.26) | (0.07) | 0.83 | (0.06) | 0.12 | — |
Capex per Share |
(0.04) | (0.03) | (0.03) | (0.06) | (0.09) | (0.11) | (0.12) | 0.00 | — |
Free Cash Flow per Share |
0.58 | 0.14 | 0.09 | (0.33) | (0.16) | 0.72 | (0.19) | 0.12 | — |
Cash per Share |
0.95 | 0.44 | 0.23 | 0.10 | 0.18 | 0.97 | 0.02 | 0.04 | — |
Shareholders Equity per Share |
0.96 | (0.64) | (0.68) | (0.03) | 3.73 | 1.88 | 0.00 | 1.85 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
0.96 | (0.64) | (0.68) | (0.03) | 3.73 | 1.88 | 0.00 | 1.85 | — |
Free Cash Flow |
118.41 | 26.32 | 16.56 | (60.41) | (27.30) | 101.38 | (25.35) | 21.60 | — |
Working Capital |
135.78 | (9.50) | (39.87) | (56.75) | (65.62) | 80.23 | 17.00 | 17.00 | — |
Capital Expenditures |
(7.44) | (6.32) | (6.12) | (12.01) | (15.95) | (15.24) | (16.64) | (19.58) | — |
Net Current Asset Value |
(1,257.69) | (1,394.27) | (1,427.67) | (1,448.32) | (1,419.34) | (1,238.34) | 186.00 | (991.00) | — |
EV/EBIT |
11.44 | 16.07 | 237.97 | 0.00 | 0.00 | 404.98 | 404.98 | 404.98 | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | — |
Price to Operating Income |
6.48 | 6.31 | 64.95 | 0.00 | 0.00 | 245.68 | 245.68 | 245.68 | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
2.05 | 2.11 | 6.83 | 31.73 | 5.16 | 3.48 | 0.42 | 0.44 | — |
Cash ROIC |
6.39% | 1.87% | 1.22% | (4.19%) | (1.35%) | 6.43% | (2.33%) | 1.65% | — |
Accounts Receivable Turnover |
8.20 | 7.74 | 8.04 | 7.93 | 8.27 | 8.67 | 7.80 | 7.06 | — |
Accounts Payable Turnover |
47.45 | 41.73 | 34.77 | 25.39 | 20.79 | 27.40 | 47.30 | 42.70 | — |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
7.19 | 9.57 | 8.46 | 13.19 | 16.91 | 19.88 | 7.30 | 9.01 | — |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
296.89 | 261.73 | 235.72 | 225.46 | 203.08 | 172.44 | 177.50 | 177.50 | — |
Average Payables |
34.20 | 33.28 | 37.38 | 48.62 | 54.65 | 37.98 | 20.40 | 20.40 | — |
Average Assets |
1,837.89 | 1,638.19 | 1,662.37 | 2,023.07 | 2,089.19 | 1,697.51 | 775.50 | 775.50 | — |
Average Common Equity |
35.46 | (126.56) | (67.94) | 314.75 | 450.43 | 267.52 | 307.50 | 307.50 | — |
Columns are period end dates